OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.580
-0.040 (-2.47%)
At close: Nov 20, 2024, 4:00 PM
1.590
+0.010 (0.63%)
Pre-market: Nov 21, 2024, 6:29 AM EST
OPKO Health Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for OPKO Health stock have an average target of 2.75, with a low estimate of 2.25 and a high estimate of 3.00. The average target predicts an increase of 74.05% from the current stock price of 1.58.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 26, 2024.
Analyst Ratings
The average analyst rating for OPKO Health stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +89.87% | Sep 26, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +42.41% | Sep 20, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $3 | Buy | Reiterates | $3 | +89.87% | Sep 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +89.87% | Sep 17, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $1.5 → $2.25 | Buy | Maintains | $1.5 → $2.25 | +42.41% | Aug 8, 2024 |
Financial Forecast
Revenue This Year
709.00M
from 863.50M
Decreased by -17.89%
Revenue Next Year
712.54M
from 709.00M
Increased by 0.50%
EPS This Year
-0.30
from -0.25
EPS Next Year
-0.30
from -0.30
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 764.6M | 835.8M | 839.9M |
| Avg | 709.0M | 712.5M | 750.0M |
| Low | 668.4M | 625.2M | 671.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -11.5% | 17.9% | 17.9% |
| Avg | -17.9% | 0.5% | 5.3% |
| Low | -22.6% | -11.8% | -5.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.25 | -0.08 | 0.01 |
| Avg | -0.30 | -0.30 | -0.13 |
| Low | -0.36 | -0.47 | -0.24 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.